FDA product code QTA: Ngs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis

QTA is the FDA product code for ngs whole genome sequencing for sars-cov-2 genetic analysis. It is a Not classified device, reviewed by the Microbiology panel. Devices under QTA reach the market by PMA; FDA lists no cleared 510(k)s for it.

Definition

This is an IVD test which utilizes a next generation sequencing (NGS) method performed on a high throughput sequencing platform. This test can identify and differentiate SARS-CoV-2 and support additional genetic analysis, when clinically indicated, from SARS-CoV-2-positive samples identified as positive using an EUA authorized diagnostic test. Testing is limited to designated laboratories.

Classification

FieldValue
Device nameNgs Whole Genome Sequencing For Sars-Cov-2 Genetic Analysis
Device classNot classified
Review panelMI — Microbiology
Medical specialtyUnknown
Premarket routePMA

Recalls for QTA devices

FDA recall records list no recalls for product code QTA.

Frequently asked questions

What is FDA product code QTA?

QTA is the FDA product code for ngs whole genome sequencing for sars-cov-2 genetic analysis. It is a Not classified device, reviewed by the Microbiology panel.

What device class is QTA?

Not classified. Typical premarket route: PMA.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Microbiology product codes · FDA product code lookup · 510(k) database search · 510(k) review times